Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that it will present new findings ...
When I got into that preschool classroom, I forgot about my HIV diagnoses...I couldn’t have time to be helpless.' Gwendolyn Sullivan said.
More than 60 abstracts will be presented from the ViiV portfolio, including updates from the phase 1 crossover study, the first comparing the acceptability and tolerability of long acting cabotegravir ...
Data from the CLARITY study will provide insights on acceptability and tolerability of single-dose cabotegravir and lenacapavir long-acting injections Four-year analysis from the OPERA cohort ...
The monthly District Planning and Development Board (DPDB) meeting for Wokha district was held on October 10 at the DC’s ...
As the world celebrates the International Day of the Girl Child, the AIDS Healthcare Foundation (AHF) Nigeria has renewed ...
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that it will deliver data from six presentations at IDWeek 2025, including clinical data, ...
As a medical doctor in Nigeria, Dr. Oluwatobi Oladeji often witnessed families traveling for hours to reach a clinic, only to ...
The PLHIVs under National Empowerment Network of People Living with HIV/AIDS in Kenya (NEPHAK) also want clarity on user fees ...
Through its Girls Act program, AHF empowers girls and young women in nearly 40 countries with the knowledge, support, ...
Despite being one of the most gung-ho supporters of Gov. RON DESANTIS — someone who helped him rocket to conservative stardom ...
6d
Huge breakthrough for stroke victims as doctors trial 'game-changing' pill that 'regrows' the brain
A major new clinical trial seeks to prove that a medicine used to fight a virus can also help the brain repair itself, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback